Table 3.
Antimicrobial class | Antimicrobial |
All Cases N (%)a N = 254 |
S. soneii N (%)a N = 88 |
S. flexneri N (%)a N = 152 |
S. boydii N (%)a N = 12 |
S. dysenteriae N (%)a N = 2 |
Aminoglycoside | Gentamicin | 3 (1.0) | 1 (1.0) | 1 (1.0) | 1 (8.0) | 0 (0.0) |
Kanamycin | 4 (2.0) | 2 (3.0) | 2 (2.0) | 0 (0.0) | 0 (0.0) | |
Streptomycin | 212 (85.0) | 87 (99.0) | 112 (76.0) | 11 (92.0) | 2 (100.0) | |
Beta-lactams | Ampicillin | 141 (61.0) | 45 (58.0) | 87 (61.0) | 8 (67.0) | 1 (50.0) |
Amoxicillin | 117 (47.0) | 36 (41.0) | 72 (49.0) | 8 (67.0) | 1 (50.0) | |
Ceftriaxone | 3 (2.0) | 1 (2.0) | 1 (1.0) | 0 (0.0) | 1 (50.0) | |
Quinolones | Ciprofloxacin | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Nalidixic acid | 1 (0.4) | 0 (0.0) | 1 (1.0) | 0 (0.0) | 0 (0.0) | |
Phenicol | Chloramphenicol | 37 (15.0) | 2 (2.0) | 35 (23.0) | 0 (0.0) | 0 (0.0) |
Sulfonamide | Trimethoprim sulfamethoxazole | 210 (83.0) | 82 (93.0) | 118 (78.0) | 9 (75.0) | 1 (50.0) |
Tetracycline | Tetracycline | 238 (96.0) | 83 (94.0) | 143 (97.0) | 10 (91.0) | 2 (100.0) |
Level of resistance |
All Cases N (%)a N = 254 |
S. soneii N (%)a N = 88 |
S. flexneri N (%)a N = 152 |
S. boydii N (%)a N = 12 |
S. dysenteriae N (%)a N = 2 |
|
No resistance | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Resistance to one antimicrobial class | 15 (5.9) | 3 (3.4) | 12 (7.9) | 0 (0.0) | 0 (0.0) | |
Resistance to two antimicrobial classes | 37 (14.6) | 2 (2.3) | 31 (20.4) | 3 (25.0) | 1 (50.0) | |
Resistance to three antimicrobial classes | 66 (26.0) | 39 (44.3) | 24 (15.8) | 3 (25.0) | 0 (0.0) | |
Resistance to four antimicrobial classes | 121 (47.6) | 42 (47.7) | 73 (48.0) | 6 (50.0) | 0 (0.0) | |
Resistance to five antimicrobial classes | 15 (5.9) | 2 (2.3) | 12 (7.9) | 0 (0.0) | 1 (50.0) | |
Multidrug-resistanceb | 120 (51.3) | 44 (56.4) | 68 (47.9) | 7 (58.3) | 1 (50.0) |
aProportions based on non-missing data
bResistance to ampicillin and trimethoprim-sulfamethoxazole (AT/S)